Get the Stockscreener App
0.8944
6.40%
0.0538
After Hours:
.93
0.0356
+3.98%
Palatin Technologies Inc. stock is traded at $0.8944, with a volume of 319.69K.
It is up +6.40% in the last 24 hours and down -45.13% over the past month.
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific therapeutics for the treatment of various diseases in the United States. The company's principal product is Vyleesi, an on demand subcutaneous injectable product that has completed Phase III clinical studies for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. Its drug development programs also include melanocortin receptor system program, such as PL-8177, a selective melanocortin receptor 1 agonist peptide for inflammatory bowel diseases; and PL-8331, a preclinical development candidate for treating ocular inflammation, as well as melanocortin receptor 4 peptides and orally-active small molecules to treat genetic metabolic and obesity disorders. In addition, the company develops natriuretic peptide receptor systems comprising PL3994, a natriuretic peptide receptor-A agonist, which has completed Phase I clinical study for the treatment of cardiovascular indications; and PL-5028, a dual natriuretic peptide receptor A and C agonist that is in preclinical development for cardiovascular diseases, such as reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.
See More
Previous Close:
$0.8406
Open:
$0.84
24h Volume:
319.69K
Relative Volume:
1.56
Market Cap:
$17.38M
Revenue:
$7.10M
Net Income/Loss:
$-31.59M
P/E Ratio:
-0.3494
EPS:
-2.56
Net Cash Flow:
$-26.75M
1W Performance:
-26.08%
1M Performance:
-45.13%
6M Performance:
-52.17%
1Y Performance:
-40.77%
1-Day Range:
$0.807
$0.90
1-Week Range:
$0.68
$1.2599
52-Week Range:
$0.68
$5.65
Palatin Technologies Inc. Stock (PTN) Company Profile
Name
Palatin Technologies Inc.
Sector
Industry
Phone
609-495-2200
Address
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-15 | Reiterated | Canaccord Genuity | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| May-23-12 | Initiated | Noble Financial | Buy |
| Jan-23-07 | Initiated | Next Generation | Buy |
Palatin Technologies Inc. Stock (PTN) Latest News
An Analysis of Palatin Technologies Inc. (PTN)’s Potential Price Growth - Knox Daily
PTN Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Palatin Technologies Inc (PTN) Q4 2024 Earnings Report Preview: What To Expect - GuruFocus.com
Stock Market Recap: Palatin Technologies Inc. (PTN) Concludes at 0.84, a -11.27 Surge/Decline - The Dwinnex
PTN underperforms with a -1.39 decrease in share price - US Post News
Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results - Marketscreener.com
Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results - StockTitan
Market Momentum: Palatin Technologies Inc. (PTN) Registers a -15.70 Decrease, Closing at 1.02 - The Dwinnex
Palatin Technologies (NYSEAMERICAN:PTN) Share Price Crosses Above 200-Day Moving Average of $0.00 - Defense World
Palatin Technologies stock hits 52-week low at $1.25 By Investing.com - Investing.com Australia
Palatin Technologies stock hits 52-week low at $1.25 - Investing.com India
Palatin Technologies stock hits 52-week low at $1.25 - Investing.com
Planet Fitness (NYSE:PLNT) Sets New 12-Month High at $84.69 - MarketBeat
Palantir Technologies Inc [PLTR] Records 200-Day SMA of $23.71 - Knox Daily
Palantir Stock Hits 52-Week Highs Thursday: What's Going On? - Benzinga
Pharvaris initiated with a Buy at JonesResearch - TipRanks
Pliant Therapeutics (NASDAQ:PLRX) Sees Strong Trading Volume - Defense World
Palantir Stock Is Skyrocketing. 1 Analyst Thinks It Has Another 38% Gain Ahead. - MSN
Palantir Technologies (NYSE:PLTR) Shares Up 0.6% - MarketBeat
Priority Technology (NASDAQ:PRTH) Hits New 52-Week High at $6.90 - Defense World
PRTH stock soars to 52-week high, touches $6.87 amid growth - Investing.com
PLRX’s 52-Week Rollercoaster: From $10.29 to $19.62 – What’s Next for Investors? - The InvestChronicle
Quest Partners LLC Purchases New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Arizona State Retirement System Boosts Stock Position in Photronics, Inc. (NASDAQ:PLAB) - Defense World
Priority technology executive sells shares worth over $61,000 By Investing.com - Investing.com Canada
Priority Technology (NASDAQ:PRTH) Shares Gap Up to $6.02 - MarketBeat
Pliant Therapeutics (NASDAQ:PLRX) Sees Large Volume Increase - MarketBeat
What is the investor’s view on Pliant Therapeutics Inc (PLRX)? - US Post News
Statera Biopharma (NASDAQ:STAB) & Pliant Therapeutics (NASDAQ:PLRX) Financial Analysis - Defense World
PLTR’s 2023 Market Saga: Unraveling the Story of Gains and Losses - The InvestChronicle
American Century Companies Inc. Grows Position in Photronics, Inc. (NASDAQ:PLAB) - Defense World
PLRX’s latest rating updates from top analysts. - Knox Daily
Needham upgrades Personalis Inc (PSNL) stock to a Buy - Knox Daily
Pliant Therapeutics (NASDAQ:PLRX) Shares Gap Up to $12.00 - MarketBeat
Ratio Review: Analyzing Pliant Therapeutics Inc (PLRX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Palantir (PLTR) Up ~1%, New 52 Week High of $36.08, BofA Out Positive on the Open - StreetInsider.com
This trade activity should not be overlooked: Pliant Therapeutics Inc (PLRX) - SETE News
Bokf Na Has $580,000 Stake in Photronics, Inc. (NASDAQ:PLAB) - Defense World
Photronics, Inc. (NASDAQ:PLAB) Stake Lessened by Rhumbline Advisers - Defense World
Pantheon Resources names new US-based CFO - Proactive Investors UK
Victory Capital Management Inc. Raises Stock Position in Photronics, Inc. (NASDAQ:PLAB) - MarketBeat
Victory Capital Management Inc. Acquires 86,938 Shares of Photronics, Inc. (NASDAQ:PLAB) - Defense World
TD Asset Management Inc Grows Position in Photronics, Inc. (NASDAQ:PLAB) - Defense World
Ashton Thomas Private Wealth LLC Takes Position in Photronics, Inc. (NASDAQ:PLAB) - Defense World
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Does Palantir’s AI Push Make It a Buy Now? - TradingView
Pantheon director buys £3.1m shares in private equity shopping spree - Citywire Wealth Manager
Palatin Technologies Inc. (PTN) receives a Buy rating from Canaccord Genuity - Knox Daily
Palatin advances on multiple clinical programs, eyes key milestones By Investing.com - Investing.com Australia
Palatin advances on multiple clinical programs, eyes key milestones - Investing.com
Palatin advances on multiple clinical programs, eyes key milestones - Investing.com India
Palatin Technologies Inc. Stock (PTN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):